News & Events

Roundtable Virtual Event: Business Development Forum

Nov. 24 2020 By Zoom
Join us to discuss topics that shape the way we think about tech transfer
Moderated by Ariel Rabin, VP Business Development, Hadasit

ITTN Annual Report 2019

In our second year of reporting The Israeli Tech Transfer Network, ITTN, is pleased to share the Annual Report 2019


20 August 2020
Matricelf has been selected as a “one to watch” for the Nature Research Spinoff Prize. This reward and recognition will bring Matricelf one step closer to becoming a global leader in personalized regenerative medicine .

Personalized Nutrition - DAYTWO

13 July 2020
DayTwo is a start-up that provides personalized nutrition recommendations, which help balance individual blood sugar levels. In the following article, DayTwo Co-Founder and CEO Lihi Segal discusses the importance of health-tech and how the company copes with the current pandemic crisis.

TROBIX BIO selected as "One to watch" in this year SPINOFF PRIZE

6 July 2020
Trobix Bio and Ramot at Tel Aviv University are proud to announce that Trobix Bio has been selected as a “one to watch” for the Nature Research Spinoff Prize. This award is a steppingstone for sharing the story behind Trobix Bio’s technology, and a pier testimonial to the unique approach the company is taking to tackle antimicrobial resistance.

Lysogene partners with Weizmann Institute

1 July 2020
July 1, 2020 -- Lysogene has inked a research agreement with Yeda Research and Development, the commercial arm of the Weizmann Institute of Science, for novel gene therapy.

BAYER PHARMACEUTICALS will test new drugs using human heart tissues 3D-Printed in Tel Aviv University

29 June 2020
Ramot at Tel Aviv University signed a collaboration agreement with Bayer to develop and validate a platform for in vitro cardiotoxicity screening, using human heart tissues 3D-printed in Prof. Tal Dvir’s Laboratory for Tissue Engineering and Regenerative Medicine. In upcoming years, Prof. Dvir’s team and Bayer plan to test new medication for toxicity and efficacy using printed whole human hearts.

Immunodominant epitopes identified for designing based vaccine against SARS -COV 2

14 June 2020
In a study just published in the journal MDPI Vaccines, researchers from Bar-Ilan University have identified a set of potential immunodominant epitopes from the SARS-CoV-2 proteome.

Researchers develop technology that transforms tap water into powerful enviromentally - friendly disinfectant against viruses, including Coronavirus

08 June 2020
searchers from Bar-Ilan University have developed new methodologies to produce powerful, environmentally-friendly disinfectants, based on tap water, that can eliminate bacteria and kill viruses, including microbes from the coronavirus family. The ability to turn ordinary tap water into virus-fighting materials was developed and patented by Dr. Eran Avraham, Dr. Izaak Cohen, and Prof. Doron Aurbach

RAMOT@TAU is collaborating with Biological Industries ISRAEL BEIT HAEMEK LTD. and THE ISRAEL DEFENSE FORCES (IDF) to detect antibodies and immune response to Cornavirus using a highly sensitive and specific serological assay developed at TAU

18 May 2020
A TAU team led by Prof. Motti Gerlic and Prof. Ariel Munitz, both of TAU's Sackler Faculty of Medicine of Tel Aviv University, have developed a new test to add to the current diagnostic arsenal used to detect coronavirus infection. The unique test is serological — a blood test — and measures the presence of three type of antibodies against the virus.